Enhancement of platelet inhibition of ticlopidine plus aspirin vs aspirin alone given prior to elective PTCA

被引:12
作者
van de Loo, A
Nauck, M
Noory, E
Just, H
Wollschlager, H
机构
[1] Univ Klin Freiburg, Med Klin 3, D-79106 Freiburg, Germany
[2] Zent Lab, Freiburg, Germany
关键词
ticlopidine; aspirin; platelet aggregation; percutaneous transluminal coronary angioplasty; stent;
D O I
10.1053/euhj.1997.0740
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In man. patients today, elective percutaneous transluminal coronary angioplasty is followed by implantation of coronary stents to achieve optimal results. The current medical strategy to prevent early reocclusion is the inhibition of platelet aggregation by administration of. ticlopidine, in addition to aspirin, immediately after the procedure. Tn order to inhibit platelet aggregation as early as possible, many centres begin to treat patients with additional ticlopidine the day before elective coronary intenvention. The aim of this study was to determine the effect of this strategy on platelet aggregation before angioplasty. Method Fifty-two consecutive patients admitted to hospital for elective balloon angioplasty were prospectively randomized to receive either standard oral aspirin 100 mg per day or standard therapy plus 250 mg ticlopidine at the time of admission and the morning before angioplasty. Adenosine diphosphate-, collagen- and epinephrine-induced platelet aggregation was measured immediately before the procedure by an investigator who was blinded concerning the arm of therapy. Results The two groups of patients were comparable in terms of age, sex, body mass index, anginal state, time interval between application of study drug and coronary intervention. Patients on aspirin and ticlopidine had a mean maximal platelet aggregation of 36 +/- 12% with adenosine diphosphate as agonist. For the control group, 54 +/- 12% was measured (P < 0.001). Myocardial infarction or emergency coronary bypass grafting did not occur in either group. Local haemorrhagic complications at the arterial access site occurred in five (aspirin) and sis (aspirin and ticlopidine) patients (P=ns) none of them requiring blood transfusion. Conclusion The additional application of ticlopidine to chronic aspirin therapy the day before elective coronary balloon angioplasty leads to a significantly higher inhibition of platelet aggregation at the time of the intervention. It seems to be safe compared to the standard procedure.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 40 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]   PREVENTION OF PLATELET HYPERAGGREGATION DURING CORONARY ANGIOGRAPHY [J].
AMMATURO, V ;
PERRICONE, C ;
ZUCCARELLI, B ;
MININNI, N ;
COLUSSI, L ;
CANAZIO, A ;
PALUMBO, E .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1986, 14 (04) :185-187
[3]   ASPIRIN AND DIPYRIDAMOLE IN THE PREVENTION OF ACUTE CORONARY-THROMBOSIS COMPLICATING CORONARY ANGIOPLASTY [J].
BARNATHAN, ES ;
SCHWARTZ, JS ;
TAYLOR, L ;
LASKEY, WK ;
KLEAVELAND, JP ;
KUSSMAUL, WG ;
HIRSHFELD, JW .
CIRCULATION, 1987, 76 (01) :125-134
[4]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[5]  
COLMAN RW, 1994, MECH PLATELET AGGREG
[6]   INTRACORONARY STENTING WITHOUT ANTICOAGULATION ACCOMPLISHED WITH INTRAVASCULAR ULTRASOUND GUIDANCE [J].
COLOMBO, A ;
HALL, P ;
NAKAMURA, S ;
ALMAGOR, Y ;
MAIELLO, L ;
MARTINI, G ;
GAGLIONE, A ;
GOLDBERG, SL ;
TOBIS, JM .
CIRCULATION, 1995, 91 (06) :1676-1688
[7]   PHARMACOLOGY OF TICLOPIDINE - A REVIEW [J].
DEFREYN, G ;
BERNAT, A ;
DELEBASSEE, D ;
MAFFRAND, JP .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1989, 15 (02) :159-166
[8]   CLINICAL PHARMACOKINETICS OF TICLOPIDINE [J].
DESAGER, JP .
CLINICAL PHARMACOKINETICS, 1994, 26 (05) :347-355
[9]  
DIRSCHINGER J, 1996, CIRCULATION, V94, P257
[10]   A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE [J].
FISCHMAN, DL ;
LEON, MB ;
BAIM, DS ;
SCHATZ, RA ;
SAVAGE, MP ;
PENN, I ;
DETRE, K ;
VELTRI, L ;
RICCI, D ;
NOBUYOSHI, M ;
CLEMAN, M ;
HEUSER, R ;
ALMOND, D ;
TEIRSTEIN, PS ;
FISH, RD ;
COLOMBO, A ;
BRINKER, J ;
MOSES, J ;
SHAKNOVICH, A ;
HIRSHFELD, J ;
BAILEY, S ;
ELLIS, S ;
RAKE, R ;
GOLDBERG, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :496-501